Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
10.26
-0.21 (-2.01%)
At close: Aug 15, 2025, 3:59 PM
10.24
-0.15%
After-hours: Aug 15, 2025, 06:01 PM EDT
Phathom Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 149.57M | 212.31M | 297.26M | 334.68M | 276.24M | 322.23M | 381.39M | 213.68M | 248.85M | 129.57M | 155.38M | 196.84M | 207.39M | 138.09M | 183.26M | 224.62M | 209.67M | 237.97M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 2.86M | n/a | n/a | n/a | 2.86M | 2.87M | 2.86M | 2.86M | 528K | n/a | 505K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 26.37M | 27.57M | 16.09M | 10.73M | 8.86M | 10.09M | 9.93M | 3.75M | 3.75M | 804K | 299K | 1.78M | 805K | 805K | 341K | 341K | 291K | 385K |
Receivables | 51.26M | 36.36M | 38.8M | 21.05M | 10.88M | 3.88M | 1.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 3.43M | 3.17M | 3.21M | 3.11M | 2.18M | 1.46M | 1.21M | 111K | 111K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 14.62M | 13.05M | 20.87M | 14.98M | 15.5M | 12.75M | 13.19M | 12.94M | 8.76M | 10.27M | 5.13M | 975K | 1.86M | 7.65M | 3.27M | 695K | 1.67M | 4.84M |
Total Current Assets | 218.88M | 264.9M | 360.13M | 373.82M | 304.79M | 340.31M | 397.43M | 226.73M | 257.72M | 139.84M | 160.51M | 196.84M | 209.26M | 145.74M | 186.53M | 225.31M | 211.34M | 242.81M |
Property-Plant & Equipment | 2.12M | 1.74M | 2.09M | 2.49M | 2.86M | 3.23M | 3.62M | 3.66M | 3.04M | 3.36M | 3.49M | 3.31M | 3.44M | 2.5M | 2.56M | 2.72M | 2.95M | 3.17M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 31.34M | 29.31M | 18.18M | 13.22M | 14.59M | 16.18M | 16.41M | 10.27M | 7.32M | 4.17M | 4.3M | 5.09M | 4.25M | 3.31M | 2.9M | 3.06M | 3.24M | 3.55M |
Total Assets | 250.22M | 294.21M | 378.32M | 387.04M | 319.38M | 356.5M | 413.84M | 236.99M | 265.04M | 144.01M | 164.81M | 201.93M | 213.5M | 149.05M | 189.43M | 228.38M | 214.58M | 246.36M |
Account Payables | 4.01M | 11.62M | 10.51M | 7.13M | 7.66M | 8.4M | 12.6M | 5.79M | 4.17M | 4.73M | 10M | 7.13M | 5.76M | 2.86M | 5.15M | 5.58M | 5.4M | 10.86M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 18.34M | 15.1M | 16.41M | n/a | n/a | n/a | -559K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 21.76M | n/a | n/a | n/a | 9.91M | 16.48M | n/a | n/a | n/a | n/a | n/a | n/a | 628K | 490K | n/a | 484K | 10.82M | 12.24M |
Other Current Liabilities | 47.34M | 62.41M | 36.44M | 57.48M | n/a | n/a | 12.14M | 10.16M | 10.12M | 3.49M | n/a | 945K | 8.86M | 4.96M | n/a | 16.5M | 19.02M | 15.44M |
Total Current Liabilities | 91.82M | 74.03M | 85.73M | 65.29M | 47.01M | 43.46M | 38.78M | 23.98M | 21.55M | 14.44M | 26.24M | 22.88M | 21.07M | 11.39M | 18.92M | 27.81M | 39.61M | 40.84M |
Long-Term Debt | 552.14M | 547.05M | 201.41M | 175.73M | 495.61M | 451.55M | 137.84M | 99.26M | 97.81M | 96.64M | 95.26M | 93.88M | 92.43M | 91.04M | 89.67M | 88.31M | 37.34M | 35.59M |
Other Long-Term Liabilities | 11.5M | 558.55M | 344.76M | 333.14M | 10.45M | 9.7M | 309.52M | 130.9M | 127.3M | 122.18M | 117.03M | 110.35M | 105.6M | 7.5M | 7.5M | 7.5M | 4.13M | 4.13M |
Total Long-Term Liabilities | 564.23M | 558.55M | 546.17M | 508.87M | 506.2M | 461.54M | 447.82M | 230.79M | 225.89M | 219.76M | 213.39M | 205.47M | 199.43M | 99.62M | 98.35M | 97.08M | 42.84M | 41.18M |
Total Liabilities | 656.05M | 632.58M | 631.9M | 574.16M | 553.21M | 505M | 486.6M | 254.76M | 247.44M | 234.21M | 239.62M | 228.35M | 220.5M | 111.01M | 117.28M | 124.9M | 82.45M | 82.02M |
Total Debt | 574.5M | 564.64M | 201.91M | 176.41M | 506.38M | 469.05M | 139.03M | 100.61M | 99.31M | 98.3M | 97.07M | 95.81M | 94.45M | 92.61M | 91.34M | 90.07M | 49.54M | 49.3M |
Common Stock | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -1.43B | -1.36B | -1.26B | -1.19B | -1.1B | -1.01B | -928.68M | -849.12M | -805.87M | -764.91M | -727.09M | -672.05M | -620.96M | -570.03M | -529.37M | -493.54M | -456.88M | -420.33M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | 0.00 | -0.00 |
Shareholders Equity | -405.83M | -338.38M | -253.58M | -187.11M | -233.83M | -148.5M | -72.76M | -17.77M | 17.6M | -90.19M | -74.81M | -26.42M | -7M | 38.03M | 72.16M | 103.48M | 132.13M | 164.34M |
Total Investments | 2.86M | n/a | n/a | n/a | 2.86M | 2.87M | 2.86M | 2.86M | 528K | n/a | 505K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |